Biomarker identification in fatal and post-acute sequelae of SARS-CoV-2 (PASC) lungs leads to epigenetic targeting in PASC-related fibrosis
Espindola M, Hohman M, Sá Y, Garcia S, Creyns B, Coelho A, Yao C, Chiang G, Parimon T, Strip B, Chen P, Hogaboam C. Biomarker identification in fatal and post-acute sequelae of SARS-CoV-2 (PASC) lungs leads to epigenetic targeting in PASC-related fibrosis. 2023, 201. DOI: 10.1183/23120541.lsc-2023.201.Peer-Reviewed Original Research